173 related articles for article (PubMed ID: 212228)
1. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
Bloom SR; Polak JM
Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
[TBL] [Abstract][Full Text] [Related]
2. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
[TBL] [Abstract][Full Text] [Related]
3. [Verner-Morrison syndrome (1 case with determination of vasoactive intestinal peptide (V.I.P.) and electron microscope study)].
Lescut J; Mazzuca M; Hanon D; Ribet M
Lille Med; 1979 Mar; 24(3):189-93. PubMed ID: 226822
[No Abstract] [Full Text] [Related]
4. [Diarrheic syndrome and beta cell tumors of the pancreas: the Verner-Morrison syndrome: report of a case].
Machado MC; Bettarello A; Mott CB; Bacchella T; da Cunha JE
Rev Hosp Clin Fac Med Sao Paulo; 1981 Apr; 36(2):78-85. PubMed ID: 6275483
[No Abstract] [Full Text] [Related]
5. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
6. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
Fahrenkrug J; Schaffalitzky de Muckadell OB
Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
[TBL] [Abstract][Full Text] [Related]
7. [Vipomas].
Dupont C
Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
[TBL] [Abstract][Full Text] [Related]
8. Streptozotocin treatment in pancreatic cholera (Verner-Morrison) syndrome.
Pignal F; René E; Chayvialle JA; Rigaud D; Lehy T; Bonfils S
Digestion; 1982; 24(3):176-82. PubMed ID: 6292031
[TBL] [Abstract][Full Text] [Related]
9. [VIP and GIP-producing pancreatic tumour: relationship to the Verner-Morrison syndrome].
Kunert H; Kuhn FM; Schwemmle K; Ottenjann R
Dtsch Med Wochenschr; 1976 Jun; 101(24):920-3. PubMed ID: 179772
[TBL] [Abstract][Full Text] [Related]
10. [Islet cell carcinoma causing Verner-Morrison syndrome (author's transl)].
Rosenberger J; Stock W; Kotthoff B
Leber Magen Darm; 1979 Feb; 9(1):6-10. PubMed ID: 216865
[TBL] [Abstract][Full Text] [Related]
11. VIPoma syndrome.
Krejs GJ
Am J Med; 1987 May; 82(5B):37-48. PubMed ID: 3035922
[TBL] [Abstract][Full Text] [Related]
12. [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome].
Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
Minerva Med; 1981 Jun; 72(26):1707-11. PubMed ID: 6265832
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
[TBL] [Abstract][Full Text] [Related]
14. VIPomas and the watery diarrhoea syndrome.
Modlin IM; Bloom SR
S Afr Med J; 1978 Jul; 54(2):53-6. PubMed ID: 705537
[TBL] [Abstract][Full Text] [Related]
15. [Verner-Morrison syndrome].
Fahrenkrug J; Pedersen JH; Schaffalitzky de Muckadell OB; Stadil F
Ugeskr Laeger; 1981 Oct; 143(44):2881-4. PubMed ID: 6275594
[No Abstract] [Full Text] [Related]
16. Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment.
Bloom SR
Am J Dig Dis; 1978 Apr; 23(4):373-6. PubMed ID: 208414
[No Abstract] [Full Text] [Related]
17. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
[TBL] [Abstract][Full Text] [Related]
18. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
Devine BL; Carmichael HA; Russell RI; Joffe SN
Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
[TBL] [Abstract][Full Text] [Related]
19. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
Said SI
World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
